26.14
price down icon0.68%   -0.18
after-market Handel nachbörslich: 26.14
loading

Cg Oncology Inc Aktie (CGON) Neueste Nachrichten

pulisher
Jul 23, 2025

CG Oncology Inc. Stock Analysis and ForecastHigh-profit trading signals - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What drives CG Oncology Inc. stock priceConsistent high-yield stocks - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

Is CG Oncology Inc. a good long term investmentExplosive returns - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Why CG Oncology Inc. stock attracts strong analyst attentionSteady Income Ideas - Newser

Jul 22, 2025
pulisher
Jul 22, 2025

Why Did CG Oncology Plunge 10.78%? Insider Selling Sparks Concern - AInvest

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about CG Oncology Inc. stockConsistently high returns - PrintWeekIndia

Jul 22, 2025
pulisher
Jul 20, 2025

Teacher Retirement System of Texas Cuts Position in CG Oncology, Inc. (NASDAQ:CGON) - Defense World

Jul 20, 2025
pulisher
Jul 18, 2025

CG Oncology, Inc. (NASDAQ:CGON) Receives Consensus Rating of “Buy” from Brokerages - Defense World

Jul 18, 2025
pulisher
Jul 18, 2025

Royal Bank Of Canada Issues Pessimistic Forecast for CG Oncology (NASDAQ:CGON) Stock Price - Defense World

Jul 18, 2025
pulisher
Jul 17, 2025

September 19th Options Now Available For CG Oncology (CGON) - Nasdaq

Jul 17, 2025
pulisher
Jul 16, 2025

Beyond The Numbers: 7 Analysts Discuss CG Oncology Stock - Benzinga

Jul 16, 2025
pulisher
Jul 16, 2025

CG Oncology stock price target lowered to $53 at RBC Capital - Investing.com Canada

Jul 16, 2025
pulisher
Jul 15, 2025

How CG Oncology Inc. stock performs during market volatilityFree Stock Selection - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes CG Oncology Inc. stock price move sharplyFree Stock Movement Tracking - Newser

Jul 15, 2025
pulisher
Jul 12, 2025

Morgan Stanley Lifts PT on CG Oncology (CGON) to $56, Keeps an Overweight Rating - MSN

Jul 12, 2025
pulisher
Jul 12, 2025

CG Oncology Appoints Interim CFO After Resignation - The Globe and Mail

Jul 12, 2025
pulisher
Jul 12, 2025

The Goldman Sachs Group Upgrades CG Oncology (NASDAQ:CGON) to “Strong-Buy” - Defense World

Jul 12, 2025
pulisher
Jul 07, 2025

Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs - Finansavisen

Jul 07, 2025
pulisher
Jul 06, 2025

CG Oncology's Strategic Pivot: How the Creto Pipeline is Redefining Value in Oncology Drug Development - AInvest

Jul 06, 2025
pulisher
Jun 28, 2025

CG Oncology (NASDAQ:CGON) Upgraded to “Hold” at Wall Street Zen - Defense World

Jun 28, 2025
pulisher
Jun 23, 2025

CG Oncology: Looking Undervalued Heading Toward FDA Submission (Upgrade) (NASDAQ:CGON) - Seeking Alpha

Jun 23, 2025
pulisher
Jun 18, 2025

Cancer Rates Are Surging in Young Adults -- Here's Where the Smart Money Is Going - KamloopsBCNow

Jun 18, 2025
pulisher
Jun 18, 2025

Cancer Rates Are Surging in Young Adults — Here’s Where the Smart Money Is Going - Cantech Letter

Jun 18, 2025
pulisher
Jun 18, 2025

CG Oncology (NASDAQ:CGON) Price Target Raised to $56.00 at Morgan Stanley - Defense World

Jun 18, 2025
pulisher
Jun 18, 2025

Rhumbline Advisers Buys 5,673 Shares of CG Oncology, Inc. (NASDAQ:CGON) - Defense World

Jun 18, 2025
pulisher
Jun 18, 2025

CG Oncology (NASDAQ:CGON) Trading 4.7% Higher After Analyst Upgrade - Defense World

Jun 18, 2025
pulisher
Jun 17, 2025

CGON: Morgan Stanley Raises Price Target for CG Oncology | CGON Stock News - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

CG Oncology price target raised to $56 from $52 at Morgan Stanley - TipRanks

Jun 17, 2025
pulisher
Jun 17, 2025

August 15th Options Now Available For CG Oncology (CGON) - Nasdaq

Jun 17, 2025
pulisher
Jun 16, 2025

Non-Muscle Invasive Bladder Cancer Market Set to Grow Substantially Through 2034, DelveInsight Projects | CG Oncology, Pfizer, UroGen Pharma, Janssen Research & Development, LLC, Protara Therapeutics - The Globe and Mail

Jun 16, 2025
pulisher
Jun 12, 2025

Cantor Fitzgerald Predicts CG Oncology FY2026 Earnings - Defense World

Jun 12, 2025
pulisher
Jun 10, 2025

California State Teachers Retirement System Buys 20,763 Shares of CG Oncology, Inc. (NASDAQ:CGON) - Defense World

Jun 10, 2025
pulisher
Jun 07, 2025

Squarepoint Ops LLC Makes New Investment in CG Oncology, Inc. (NASDAQ:CGON) - Defense World

Jun 07, 2025
pulisher
Jun 05, 2025

CG Oncology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference - Bluefield Daily Telegraph

Jun 05, 2025
pulisher
Jun 05, 2025

CG Oncology Brings Breakthrough Bladder Cancer Treatment to Goldman Sachs Healthcare Conference - Stock Titan

Jun 05, 2025
pulisher
Jun 04, 2025

Ameriprise Financial Inc. Grows Stock Holdings in CG Oncology, Inc. (NASDAQ:CGON) - Defense World

Jun 04, 2025
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Kapitalisierung:     |  Volumen (24h):